Inhaled nitric oxide therapy in neonates and children: reaching a European consensus

Abstract

Inhaled nitric oxide (iNO) was first used in neonatal practice in 1992 and has subsequently been used extensively in the management of neonates and children with cardiorespiratory failure. This paper assesses evidence for the use of iNO in this population as presented to a consensus meeting jointly organised by the European Society of Paediatric and Neonatal Intensive Care, the European Society of Paediatric Research and the European Society of Neonatology. Consensus Guidelines on the Use of iNO in Neonates and Children were produced following discussion of the evidence at the consensus meeting.

DOI: 10.1007/s00134-003-2122-3
0200400'04'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

1,304 Citations

Semantic Scholar estimates that this publication has 1,304 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Macrae2003InhaledNO, title={Inhaled nitric oxide therapy in neonates and children: reaching a European consensus}, author={Duncan John Macrae and David J Field and J. C. Mercier and Jens Chr. M\oller and Tom Arne Stiris and Paolo Biban and Paul Cornick and Allan P. Goldman and Sylvia G{\"{o}thberg and Lars E. Gustafsson and Juerg Hammer and Per-Arne L{\"{o}nnqvist and Manuel S{\'a}nchez-Luna and Gunnar Sedin and Nimish V. Subhedar}, journal={Intensive Care Medicine}, year={2003}, volume={30}, pages={372-380} }